A Meta-analysis of the association between interleukin-10 -1082A>G polymorphism and cervical cancer risk
GUO Chong1 ZHU Jie2
1.Department of Gynecology and Obstetrics, Taihe Hospital of Shiyan City, Hubei Province, Shiyan 442000, China;
2.Labor Union, Taihe Hospital of Shiyan City, Hubei Province, Shiyan 442000, China
Abstract:Objective To investigate the association between interleukin-10 -1082A>G polymorphism and cervical cancer risk with a Meta-analysis. Methods The databases of PubMed, Embase, Web of SCI, CNKI and Wanfang databases were searched for the relevant literatures about the association between interleukin-10 -1082A>G polymorphism and cervical cancer risk from their inception to December 31st, 2017. The data of genotype distributions and other information were extracted in the selected studies. Odds ratio (OR) and 95% confidence interval (CI) were calculated with STATA 14.0 software. Publication bias, sensitivity and cumulative analyses were also applied. Results Thirteen published case-control studies including 2311 patients with cervical cancer and 2491 controls were selected. Overall, significant elevate association between IL-10 -1082A>G polymorphism and cervical cancer risk were found in this Meta-analysis (G vs. A: OR = 1.60, 95%CI = 1.12-2.29, P = 0.01, I2 = 92.3%; AG vs. AA: OR = 1.34, 95%CI = 1.04-1.74, P = 0.03, I2 = 65.9%; AG+GG vs. AA: OR = 1.58, 95%CI = 1.11-2.25, P = 0.01, I2 = 84.4%), and the same results were obtained in the subgroup analysis based on ethnicity and control design. Conclusion This Meta-analysis demonstrates that IL-10 -1082A>G polymorphism may be a risk factor for cervical cancer development.
郭冲1 朱洁2. 白细胞介素10基因-1082A>G位点多态性与宫颈癌易感性的Meta分析[J]. 中国医药导报, 2018, 15(16): 67-71.
GUO Chong1 ZHU Jie2. A Meta-analysis of the association between interleukin-10 -1082A>G polymorphism and cervical cancer risk. 中国医药导报, 2018, 15(16): 67-71.
[1] Torre LA,Bray F,Siegel RL,et al. Global cancer statistics,2012 [J]. CA Cancer J Clin,2015,65(2):87-108.
[2] Smith HO,Tiffany MF,Qualls CR,et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study [J]. Gynecol Oncol,2000,78(2):97-105.
[3] Wang SS,Sherman ME,Hildesheim A,et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000 [J]. Cancer,2004,100(5):1035-1044.
[4] Nedovic J,Protrka Z,Ninkovic S,et al. Cisplatin monotherapy with concurrent radiotherapy versus combination of cisplatin and 5-fluorouracil chemotherapy with concurrent radiotherapy in patients with locoregionally advanced cervical carcinoma [J]. J BUON,2012,17(4):740-745.
[5] Lee CH,Chang JS,Syu SH,et al. IL-1beta promotes malignant transformation and tumor aggressiveness in oral cancer [J]. J Cell Physiol,2015,230(4):875-884.
[6] Liu H,Antony S,Roy K,et al. Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells [J]. Oncotarget,2017,8(24):38 113-38 135.
[7] Cecil DL,Holt GE,Park KH,et al. Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity [J]. Cancer Res,2014,74(10):2710-2718.
[8] Howell WM,Rose-Zerilli MJ. Cytokine gene polymorphisms,cancer susceptibility,and prognosis [J]. Journal of Nutrition,2007,137(1):194S-199S.
[9] Eskdale J,Kube D,Tesch H,et al. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence [J]. Immunogenetics,1997,46(2):120-128.
[10] Stanczuk GA,Sibanda EN,Perrey C,et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production [J]. Int J Cancer,2001,94(6):792-794.
[11] Roh JW,Kim MH,Seo SS,et al,Lee HP. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women [J]. Cancer Lett,2002,184(1):57-63.
[12] Govan VA,Carrara HR,Sachs JA,et al. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer [J]. J Carcinog,2003,2(1):3.
[13] Zoodsma M,Nolte IM,Schipper M,et al. Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease [J]. Int J Gynecol Cancer,2005, 15(3):282-290.
[14] Matsumoto K,Oki A,Satoh T,et al. Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women [J]. Jpn J Clin Oncol,2010, 40(11):1113-1116.
[15] 于晓牧,马冬,吴尚青,等.IL-10基因多态性与宫颈癌相关性的研究[J].中华医院感染学杂志,2011,21(20):239-241.
[16] Wang Q,Zhang C,Walayat S,et al. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population [J]. Eur J Obstet Gynecol Reprod Biol,2011,158(2):330-333.
[17] Barbisan G,Perez LO,Contreras A,et al. TNF-alpha and IL-10 promoter polymorphisms,HPV infection,and cervical cancer risk [J]. Tumour Biol,2012,33(5):1549-1556.
[18] Singhal P,Kumar A,Bharadwaj S,et al. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma [J]. Tumour Biol,2015,36(4):2287-2298.
[19] Zidi S,Gazouani E,Stayoussef M,et al. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians [J]. Cytokine,2015,76(2):343-347.
[20] Torres-Poveda K,Burguete-Garcia AI,Bahena-Roman M,et al. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer:a case control study [J]. BMC Cancer,2016, 16:330.
[21] Zeng YY,Chen XY,Tian KG,et al. The correlation of interleukin-10 gene polymorphism and HPV infection and cervical lesions in Dongguan region (China) [J]. J Clin Exper Med,2015,14:636-639.
[22] Bai CY,Shi XY,He J,et al. Association between IL-10 genetic variations and cervical cancer susceptibility in a Chinese population [J]. Genet Mol Res,2016,15(3):38.
[23] Liu H,Antony S,Roy K,et al. Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells [J]. Oncotarget,2017,8(24):38 113-38 135.
[24] Niu YM,Du XY,Cai HX,et al. Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer:a Meta-analysis [J]. Sci Rep,2015, 27(5):17149.